Dose-Escalated Radiotherapy Alone or in Combination With Short-Term Androgen Deprivation for Intermediate-Risk Prostate Cancer: Results of a Phase III Multi-Institutional Trial: [ Ссылка ]
Donate to PCRI: [ Ссылка ]
For more information, visit [ Ссылка ]
0:39 Should hormone therapy always accompany radiation therapy?
6:24 Should age play a role in deciding whether or not to get short-term hormone therapy?
8:01 At what point does short-term hormone therapy become with the side effects?
9:55 Is it ever appropriate to delay hormone therapy after radiation?
11:32 Alex's conclusions
13:23 If you need more help
Don't know your stage? Take the quiz: visit [ Ссылка ]
To learn more about prostate cancer, visit [ Ссылка ]
Sign up for our newsletter here to receive the latest updates on prostate cancer and the PCRI: [ Ссылка ]
Who we are:
The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better-individualized care. Feel free to explore our website at pcri.org or contact our free helpline with any questions that you have at pcri.org/helpline. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.
